written on 04.03.2014

Ranbaxy whistleblower on the perils of a globalized supply chain, fraud enablers


Countries that supply medicines to the US should be "incentivized" to upgrade their skills, comply with American quality standards and improve public health for their own citizens. And those that are repeatedly not up to scratch should face punitive…